A. John Leontakianakos
Prior to joining the company A. John Leontakianakos was employed as Sr. Vice President of Finance and VP of Business Development of Capital Genomix Inc.
Mr. Leontakianakos had also served as General Partner of Ares Venture Partners Inc., since its inception in 2000.
From 1999-2000, he served as Director and Executive VP of BioTherapeutics Inc.
From 1995 through 2000, he served as the Managing Director of Corporate Finance and as the Chief Executive Officer of Odyssey Capital & Research Group, Inc., where he created and implemented several innovative investment structures that have facilitated more than $5 billion in private investments.
From 1993-1995, he served as Executive Vice President of Corporate Finance and President of Global International Equity Corp. (USA), where he arranged funding for several public and private companies and managed a $398 million portfolio of assets on behalf of Global Security Credit Ltd. (a wholly owned subsidiary).
From 1992-1993, Mr. Leontakianakos served as Vice President of Mergers & Acquisitions for American Public Companies, Inc.
From 1985 to 1992, he was employed in the investment banking industry by such firms as Gateway Financial Group, Euro-Atlantic Securities, and Cohen & Cohen, holding such positions as Vice President of Investments, Financial Advisor, Junior Analyst and Corporate Finance Associate.
Mr. Leontakianakos has served on the Board of Directors of Odyssey Capital & Research Group, Inc., Global International Equity Corp. (USA), Global Security Credit Ltd., and Oxford & Co., Inc. He has also served on several institutional advisory boards. From 1982-1985 Mr. Leontakianakos also served honorably in the United States Marine Corp and was highly decorated as a result of his combat service with 24th Marine Amphibious Unit (24th MAU) in Beirut, Lebanon.